Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the origina...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wani RA, Dar MA, Chandel RK, Rather YH, Haq I, Hussain A, Malla AA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/32a0b5cd2d9e4624bc44e362f32dc01b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:32a0b5cd2d9e4624bc44e362f32dc01b
record_format	dspace
spelling	oai:doaj.org-article:32a0b5cd2d9e4624bc44e362f32dc01b2021-12-02T04:29:49ZEffects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]1178-2021https://doaj.org/article/32a0b5cd2d9e4624bc44e362f32dc01b2015-03-01T00:00:00Zhttp://www.dovepress.com/corrigendum-effects-of-switching-from-olanzapine-to-aripiprazole--peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the original paper Wani RADar MAChandel RKRather YHHaq IHussain AMalla AADove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 863-864 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Wani RA Dar MA Chandel RK Rather YH Haq I Hussain A Malla AA Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
description	Wani RA, Dar MA, Chandel RK, et al Title of paper should have been “Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a randomized, open-label study”.  Read the original paper
format	article
author	Wani RA Dar MA Chandel RK Rather YH Haq I Hussain A Malla AA
author_facet	Wani RA Dar MA Chandel RK Rather YH Haq I Hussain A Malla AA
author_sort	Wani RA
title	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_short	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_full	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_fullStr	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_full_unstemmed	Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
title_sort	effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [corrigendum]
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/32a0b5cd2d9e4624bc44e362f32dc01b
work_keys_str_mv	AT wanira effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT darma effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT chandelrk effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT ratheryh effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT haqi effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT hussaina effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum AT mallaaa effectsofswitchingfromolanzapinetoaripiprazoleonthemetabolicprofilesofpatientswithschizophreniaandmetabolicsyndromeadoubleblindrandomizedopenlabelstudycorrigendum
_version_	1718401175444783104

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]

Ejemplares similares